Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Avenue Therapeutics, Inc.

OTC: ATXI · Life Sciences · 1 alert · CIK 1644963

Share price
$0.2570Close, Nov 16
Market cap
$847K
Shares outstanding
3.29MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Avenue Therapeutics, Inc. filings on SEC EDGAR ↗

4:06 PM ET 10-Q
Financial Results

Avenue Therapeutics Q3 2026 Results: Net Loss of $691K, Loss Widens

Avenue Therapeutics reported a net loss of $2.1 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year period. The company currently generates no revenue and has expressed substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $107.6 million and limited cash reserves of $1.5 million.

Key figure
Net loss $691K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.